Zurück
Clifford R. Jack
Aufstrebend44Mayo Clinic
Kennzahlen
- h-Index
- —
- Zitationen
- —
- Publikationen
- —
Zusammensetzung
Evidenzstärke
50
Erst-/Letztautor
33
Seriosität
100
Erfahrungs-Indikator aus Bibliometrie und der Evidenzstärke der eigenen Studien — kein Qualitätsurteil über die Person.
Studien bei MedPulse
- Letztautor:in2026-03-05Staging Alzheimer's disease through amyloid and tau PET.
- 2026-02-011H-MR spectroscopy biomarkers are associated with plasma-derived biomarkers of amyloid-β and tau in the early phase of AD continuum.
- 2026-02-01Accelerated Cognitive Decline in Late Life Depression: The Role of Amyloid-β, Cortico-Limbic Volume, and White Matter Hyperintensities.
- 2026-02-01Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch.
- 2025-12-23Physical and Cognitive Activities and Trajectories of AD Neuroimaging Biomarkers: Longitudinal Analysis in the Mayo Clinic Study of Aging.
- 2025-12-05Integrating individualized connectome with amyloid pathology improves predictive modeling of future cognitive decline.
- Letztautor:in2025-12-01Predictive Value of Plasma Biomarkers in Tau-PET Transitions.
- Erstautor:in2025-12-01Lifetime and 10-year absolute risk of cognitive impairment in relation to amyloid PET severity: a retrospective, longitudinal cohort study.
- 2025-12-01Tabletbasierter kognitiver Test zeigt vielversprechende Ergebnisse bei der Erkennung von früh einsetzendem Alzheimer